
Lyfon-SB+ Injection
Marketer
Lichem Pharmaceuticals
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Lyfon-SB+ Injection
Combiflox Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be solely by a qualified medical practitioner. Consistent adherence to the prescribed dosage regimen is crucial; completing the entire course, even with symptom improvement, is vital to prevent treatment failure. Abrupt cessation may compromise efficacy. Potential side effects, such as nausea, vomiting, diarrhea, and dyspepsia, may occur. Severe or persistent side effects warrant immediate physician consultation. Allergic reactions (skin rashes, pruritus, edema, dyspnea) necessitate urgent medical attention. Inform your physician of all current medications prior to commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness necessitates abstention from driving. Adequate rest, nutrition, and hydration are recommended for optimal recovery. Monitoring may involve periodic laboratory tests to assess therapeutic response.
Primary Ingredients of Lyfon-SB+ Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Lyfon-SB+ Injection
Managing bacterial infections
Major Benefits of Lyfon-SB+ Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Lyfon-SB+ Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Lyfon-SB+ Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Lyfon-SB+ Injection works:
Lyfon-SB+ Injection combines Cefoperazone, a bacterial cell wall synthesis inhibitor, with Sulbactam, a beta-lactamase inhibitor. This synergistic action combats bacterial infections by both disrupting bacterial cell wall formation and overcoming bacterial resistance mechanisms that would otherwise neutralize Cefoperazone's effects.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Lyfon-SB+ Injection treatment can trigger adverse effects including facial redness, tachycardia, queasiness, dehydration, thoracic pain, and hypotension (a Disulfiram-like response).
PregnancySAFE IF PRESCRIBED
Administration of Lyfon-SB+ Injection during pregnancy is typically deemed safe. Preclinical trials using animal models revealed minimal or no harmful consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Lyfon-SB+ Injection poses no known breastfeeding safety risk. Research in humans indicates minimal drug transfer to breast milk, with no observed harm to infants.
DrivingCONSULT YOUR DOCTOR
Lyfon-SB+ Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Lyfon-SB+ Injection use in patients exhibiting renal impairment is currently scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Lyfon-SB+ Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Lyfon-SB+ Injection :
Omit a Lyfon-SB+ Injection dose? Seek medical advice immediately.
Facts to Know About Lyfon-SB+ Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-infective agents |
